Leonard Leibovici

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

Evelina Tacconelli, Elena Carrara, Alessia Savoldi et al. · The Lancet Infectious Diseases · 2017 · 5.8K citations

Bacterial Resistance, Antimicrobial Drug Discovery, Antimicrobial Susceptibility +14

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

Mical Paul, George L. Daikos, Emanuele Durante‐Mangoni et al. · The Lancet Infectious Diseases · 2018 · 593 citations

Severe Infections, Health Sciences, Antibiotics +9

Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial

Dafna Yahav, Erica Franceschini, Fidi Koppel et al. · Clinical Infectious Diseases · 2018 · 387 citations · Full text

Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial

Mical Paul, Steen Andreassen, Evelina Tacconelli et al. · Journal of Antimicrobial Chemotherapy · 2006 · 213 citations · Full text

Benefit of Appropriate Empirical Antibiotic Treatment: Thirty-day Mortality and Duration of Hospital Stay

Abigail Fraser, Mical Paul, N. Almanasreh et al. · The American Journal of Medicine · 2006 · 204 citations

Antimicrobial Susceptibility, Antibiotics, Antimicrobial Stewardship +9